Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carl Lavie and John Rizk.
Carl Lavie
Connection Strength
1.900
John Rizk
  1. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 12 01; 6(12):1451-1460.
    View in: PubMed
    Score: 0.982
  2. Low-dose aspirin for early COVID-19: does the early bird catch the worm? Expert Opin Investig Drugs. 2021 Aug; 30(8):785-788.
    View in: PubMed
    Score: 0.239
  3. Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. Drug Discov Today. 2021 02; 26(2):593-603.
    View in: PubMed
    Score: 0.229
  4. Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs. 2020 Sep; 80(13):1267-1292.
    View in: PubMed
    Score: 0.225
  5. Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19". Drugs. 2020 09; 80(14):1501-1503.
    View in: PubMed
    Score: 0.225
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.